ARCHIVES

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

A Provision Of The EARLY Bill Is Inserted Into House Appropriations For Labor, HHS

July 24, 2009

HHS Awards $85 Million For Research to Eliminate Health Disparities

November 15, 2002

NIH Braces For HHS Rulings ON Travel To Major Meetings.

July 20, 2001

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985